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The Efficacy of Pressure Ulcer Treatment 
With Cathodal and Cathodal-Anodal 
High-Voltage Monophasic Pulsed 
Current: A Prospective, Randomized, 
Controlled Clinical Trial
Anna Polak, Luther C. Kloth, Edward Blaszczak, Jakub Taradaj, Agnieszka Nawrat- 
Szoltysik, Tomasz Ickowicz, Ewa Hordynska, Andrzej Franek, Cezary Kucio
Background. Studies show that anode and cathode electrical stimulation (ES)  promotes 
the healing of wounds, but specific protocols for both electrodes are not available.
Objective. To compare the effectiveness of cathodal versus cathodal+anodal ES in the 
treatment of Category II-IV pressure ulcers (PrUs).
Design. Prospective, randomized, controlled, clinical study.
Setting. Three nursing and care centers.
Patients. Sixty-three participants with PrUs were randomly formed into a cathodal ES 
group (CG: N = 23; mean age of 79.35; SD 8.48), a cathodal+anodal ES group (CAG: 
N = 20; mean age of 79.65; SD 11.44) and a placebo ES group (PG: N = 20; mean age of 
76.75; SD 12.24).
Intervention. All patients were treated with standard wound care and high- voltage 
monophasic pulsed current (HVMPC; twin-peak impulses; 154 μs; 100 pps; 0.25 A; 
250 μC/s) for 50 minutes per day, 5 times a week, for 6 weeks. The CG, CAG, and PG 
received, respectively, cathodal, cathodal+anodal, and sham ES through electrodes placed 
on a moist gauze pad. The treatment electrode was placed on the wound, and the return 
electrode was positioned on healthy skin at least 20 cm from the PrU.
Measurements. Measurements were made at baseline, and after each of the 6 weeks 
of treatment. Primary outcome was percentage wound surface area reduction at week 6.
Results. Wound surface area decreased in the CG by 82.34% (95% confidence interval 
[CI] 70.06-94.63) and in the CAG by 70.77% (95% CI 53.51-88.04). These reductions were 
significantly greater than in the PG (40.53%; 95% CI 23.60-57.46). The CG and CAG were 
not statistically significantly different regarding treatment results.
Limitations. The time of treatment proved insufficient for PrUs to close.
Conclusions. Cathodal and cathodal+anodal HVMPC similarly reduced the area of 
 Category II-IV PrUs.
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Clinical practice guidelines recog-nize electrical stimulation (ES) as therapeutically useful in treating 
Category II, III, and IV pressure ulcers 
(PrUs).1,2
Electric currents used in wound studies 
include direct and pulsed microamper-
age current (<1 mA),3–7 low-voltage bi-
phasic pulsed current,8–10 low-voltage 
monophasic pulsed current,11–15 and 
high-voltage monophasic pulsed cur-
rent (HVMPC).16–24 The authors of the 
2014 reviews25,26 concluded that both 
low-voltage biphasic and monophasic 
currents and HVMPC can produce con-
sistently positive results in patients with 
chronic wounds. However, optimal ES 
protocols for wound treatment are not 
available yet.
Authors of clinical studies used 
HVMPC to treat venous leg ulcers,18,20 
PrUs,16,17,21–24 and diabetic foot ulcers,19 
applying also standard wound care 
(SWC) for ethical reasons. Treatment 
results were compared with control 
groups (SWC alone18,21–23 or SWC+sham 
HVMPC16,17,19,20,24). The outcomes of the 
studies16–24 indicated that HVMPC pro-
moted the healing of wounds, decreas-
ing their area more in the SWC+HVMPC 
groups than in controls.
The cited clinical studies are similar 
regarding the selection of HVMPC pa-
rameters.16–24 Their authors used twin-
peak monophasic pulses,16–24 pulse 
duration of 50–154 µs,16,18–24 and pulse 
frequency of 100–105 pps,16–24 with 
the current evoking only sensory, 
sub-motor reactions.16–24 HVMPC was 
usually applied for 3.75 to 7 hours a 
week.16–18,20,22–24 In most studies, treat-
ment sessions of 45–60 minutes were 
held 5–7 days a week.16–18,20,22–24 The 
treatment electrode was always placed 
on the wound16–24 and the return elec-
trode on healthy skin at least 15–20 cm 
from it.16–18,20,22–24
At the same time, the studies differ 
in the selection of the treatment elec-
trode polarity. Some authors only used 
the anode or the cathode to deliver 
HVMPC.17,20,24 Others used cathod-
al stimulation and anodal stimula-
tion,18,21–23 but varied the duration of 
their application. Wounds were first 
treated with cathodal  stimulation for a 
period of 1–318 or 1–222,23 weeks, and 
then anodal stimulation was applied 
until the end of treatment. In some 
studies with HVMPC, treatment started 
with negative polarity that was changed 
every week.21
The authors of studies who treated 
wounds with low-voltage rectangular 
monophasic pulsed current also varied 
in the use of cathode and anode.11–15 
In one study, only the anode was used 
as the treatment electrode.11 In others, 
both electrodes were used, but cathodal 
stimulation was always applied first.12–15 
Some researchers chose to reverse the 
treatment electrode polarity every three 
days.12–14 The authors of one study coor-
dinated it with healing progress—after 
the first 1–2 weeks of cathodal stimu-
lation, they introduced anodal stimula-
tion for 3–10 days and then changed 
polarity again.15
The different use of anode and cathode 
in the cited studies implies that specific 
protocols showing how the electrodes 
should be applied to human wounds 
are yet to be created.
Authors of the reviews of clinical27,28 
and epidemiological studies29 consider 
wound closure the crucial endpoint in 
evaluating treatment efficacy, but clin-
ical studies with ES rarely go on until 
it is achieved. We have found only one 
study in which all PrUs were treated 
with HVMPC until full closure.16 In tri-
als that terminate before wounds are 
closed, the percentage wound area 
reduction (PAR) from baseline after 
treatment lasting 4, 6, or 12 weeks is 
crucial.17–24 The time over which PrU 
surface area decreases from baseline by 
at least 50% is also important as an indi-
cator of treatment efficacy.27–29
Aim of Study
The study was designed to determine 
more information regarding the effect 
of HVMPC delivered through the cath-
ode or the cathode and anode on the 
healing of PrUs. Clinical trials compar-
ing these two types of ES applied to 
PrUs are not available in the literature.
Two research hypotheses were formu-
lated for the study. The first states that 
HVMPC delivered only by the cath-
ode or by the cathode subsequently 
replaced by the anode can effectively 
promote the healing of PrUs. According 
to the second hypothesis, the cathode 
and anode are similarly effective in 
treating PrUs, regardless of how they 
are  applied.
Both hypotheses were formulated 
based on the results of clinical17–24 and 
preclinical studies.29–42
Clinical studies16–24 provide evidence 
that HVMPC promotes the healing of 
chronic wounds. This effect can be ob-
served when such wounds are stimulat-
ed only by the cathode,17,20,24 and when 
cathodal stimulation used at the begin-
ning of treatment is replaced by anodal 
stimulation.18,22,23
Similar conclusions can be drawn from 
preclinical studies,29–42 which show that 
in cell cultures human fibroblasts,30,31 
keratinocytes,36 microvascular endothe-
lial cells,42 and epithelial cells39 migrate 
directionally toward the cathode. Ca-
thodal stimulation has been observed in 
vitro to increase DNA synthesis in hu-
man fibroblasts,32,33 and in vivo studies 
have demonstrated that cathodal stim-
ulation increases the release of vascu-
lar endothelial growth factor in animal 
skin.40 These results imply that cathodal 
stimulation can intensify cell prolifera-
tion in the wounds. From in vivo stud-
ies with animals34,35,37,38,41 it is known 
that also treating wounds first with 
the cathode and then with the anode 
is effective. The authors of the studies 
observed increased wound epitheliali-
zation,34,35,38 tensile strength,38 mRNAs 
expression of collagen-I and transform-
ing growth factor-β1,41 reduced wound 
inflammation,37 improved cell prolifera-
tion, and the remodeling of wounds.37
Methods
Study Design
A prospective, randomized, controlled, 
clinical trial was designed to compare 
PrU closure after 6 weeks of treatment 
between 3 parallel groups of patients 
receiving SWC plus cathodal ES, ca-
thodal+anodal ES, or sham ES. Ethical 
approval was granted by the Acade-
my Bioethics Commission. The trial 
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was prospectively registered with the 
 Australian-New Zealand Clinical Trials 
Registry: ANZCTRN 12614000992606.
Setting and Participants
The trial screening procedure was 
applied to patients in 3 nursing care 
centers, whose eligibility to participate 
was assessed by their physician against 
the following criteria: aged 60+, high 
risk of PrU development (below 14 
points on the Norton scale), Category 
II, III, or IV PrU of at least 0.5 cm2, and 
of duration from 1 to 12 months located 
on the pelvic girdle. The trial focused 
on chronic PrUs in elderly persons who 
frequently have co-morbidities imped-
ing normal wound healing. All treated 
ulcers were located on the pelvic girdle 
to ensure the comparability of treat-
ment results.
Patients who could not receive ES (can-
cer, electronic implants, malignancy, 
tunneling, necrotic wounds, osteomy-
elitis, PrU requiring surgical interven-
tion, metal implants in the PrU area) 
and patients with conditions impeding 
wound healing (diabetes HbA1C > 7%), 
critical wound infection, allergies to 
standard wound treatment, alcoholism) 
were excluded from the trial. After the 
study was registered with ANZCTR but 
before patient recruitment began, the 
exclusion criteria were extended to fac-
tors that could disturb wound healing 
process or inhibit the use of ES or phar-
macological therapy.
Patients’ demographics were obtained 
from standard interviews, physical ex-
aminations, and medical records. Their 
physical and mental condition, mobility, 
and incontinence were evaluated using 
the Norton scale.43 The risk of friction 
and shear, wound moisture, sensory 
perception, physical activity, and mo-
bility were measured with the Braden 
scale.44 The patients’ diet was reviewed, 
and their intake of healthy and non-
healthy nutrients and fluid losses was 
assessed. The nutritional status of pa-
tients was quantified using the Nutri-
tional Risk Score (NRS—2002).45
Wound severity at enrollment was 
 determined by a physician using 
the National Pressure Ulcer Adviso-
ry  Panel1 criteria (Category II PrUs = 
 partial-thickness loss of the dermis 
 presenting as a shallow open ulcer 
with a red pink wound bed, no slough; 
 Category III PrUs = full-thickness tissue 
loss; subcutaneous fat possibly visible, 
but not the bone, tendon, or muscles; 
Category IV PrU = full-thickness tissue 
loss; muscle/bone exposed).
Randomization
Three groups were formed of patients 
who consented to participate in the 
study (or whose legal guardians accept-
ed their participation).
Group assignment was performed us-
ing the block randomization method. 
In each of the 3 nursing care centers, a 
person uninvolved in the trial generat-
ed 4 blocks of 6 letters (combinations of 
A, B, and C) using computer software. 
To conceal the allocation sequence, 
consecutively numbered, opaque, and 
sealed envelopes were used. The prin-
cipal investigator opened them to as-
sign patients to the appropriate group 
following the completion of baseline 
measurements.
Blinding
All patients, medical personnel, and re-
searchers were blinded. The exception 
was the main investigator and principal 
physical therapist, who set the equip-
ment to apply active or sham ES. The 
person responsible for wound surface 
area measurements and statistical anal-
ysis was blinded too.
Interventions
Standard wound care program 
administered to all groups. All 
patients in the cathodal ES, 
cathodal+anodal ES, and placebo 
groups received SWC comprising 
prevention measures, wound care, 
and physical treatment under the 
supervision of the physician and 
principal investigator following 
best practices.1,2,46 Each patient was 
assessed by an interdisciplinary team 
consisting of a physician, nurse, 
physical therapist, and dietician in 
order to develop individual wound 
prevention and treatment programs 
addressing patients’ needs for PrU 
prevention and nutritional intervention, 
the optimization of the wound 
dressing protocol, and incontinence 
management.
Treatments preventing the develop-
ment of more PrUs in the patients were 
 applied, such as pressure-redistribution 
surfaces, devices, and pillows. The im-
mobile patients were repositioned by 
a nurse or physical therapist at least 
every 2 hours. Those who could move 
were requested to change position as 
often as they could.
Blood samples were tested to screen 
patients for nutritional status mark-
ers and metabolic disorders, such 
as different types of anemia, thyroid 
dysfunction, impaired glycemic con-
trol, dehydration, protein deficit, and 
 hypoalbuminemia.
The malnourished patients received 
individual nutritional support. A nurse 
or medical assistant helped them 
with meals and monitored whether 
the quantity and quality of food and 
 liquids they ingested followed the die-
tician’s guidelines. Nutritional supple-
mentation was used when  necessary 
to ensure that the patients received 
the recommended quantity of pro-
teins, vitamins, and minerals.  Patients 
who could not take in sufficient 
amounts of food were fed enterally or 
parentally.1
Patients’ wounds were regularly exam-
ined by a physician to determine the 
types of topical treatments that were 
necessary. Interventions included tissue 
debridement, infection and inflamma-
tion control, maintaining moisture bal-
ance, and monitoring wound edges and 
epithelization. Wounds were cleaned 
with antiseptics or covered with hydro-
gel and hydrocolloid dressings to trig-
ger autolysis.
Necrotic tissue was cleaned enzymati-
cally, and infected wounds were rinsed 
with antiseptics: Octenilin Wound Gel, 
Schulke, Germany (Compounds: Octen-
idine dichydrochloride; Aqua purificata; 
Propylene Glycol, Hydroxyethylcellu-
lose); Octenisept solution, Schulke, Ger-
many (Compounds: Octenidini dichy-
drochloride 0.1%; Phenoxyethanol 2%; 
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Cocamidopropyl betaine, CAPB;  sodium 
D-gluconate 30% solution; Glycerol 
85% solution; sodium hydroxide; sodi-
um chloride; purified water); Actolind 
W Solution/Gel, Polvet Healthcare 
 Teodorowski SJ (Compounds: Polyhex-
amethylene biguanide PHMB 0.1%; 
carrier substances; purified water).
Additionally, skin in the wound area was 
cleaned with Kodan Tinktur forte solu-
tion, Schülke, Germany (Compounds: 
2-Propanolum 45%; 1-Propanolum 
10%; 2-Biphenylol 0.2%; hydrogen 
peroxide; purified water) and Skinsept, 
Ecolab, Germany (Compounds: ethanol 
46%; isopropyl alcohol 27%; benzyl al-
cohol 1%; hydrogen peroxide; purified 
water).
Patients with elevated leukocyte lev-
els received antibiotics indicated by 
the results of microbiological culture 
and sensitivity tests. Topical dressings 
were selected depending on the stage 
of wound, the presence of infection, 
and the intensity of exudation. Clean 
wounds with granulation tissue were 
covered with dressings moistened with 
0.9% sodium chloride, hydrocolloid, or 
polyurethane foam dressings. Wounds 
with necrotic tissue or considerable 
exudation had hydrogel or alginate 
dressings applied. All immobile pa-
tients received low-molecular-weight 
heparin.
Cathodal electrical stimulation group 
(CG). Patients in the CG received 
SWC and cathodal HVMPC delivered 
by the Intelect Advanced Combo unit 
(Chattanooga, Tennessee), generating 
a twin-peak monophasic pulse (154 
µs) consisting of two 77-µs exponential 
pulses in rapid succession. Pulse 
frequency was 100 pps, and voltage was 
set above 100 V for amperage of 0.25 
A that did not elicit motor reactions. 
The charge delivered by the electrodes 
was 250 µC per second. Patients 
participated in five 50-minute sessions 
a week (Monday-Friday). This protocol 
was adopted because of positive results 
of earlier clinical trials on PrUs16,17,22–24 
and venous leg ulcers.18,20
Each patient was assigned a personal set 
of conductive carbon-rubber electrodes. 
The treatment electrode (5.0 × 10.0 cm) 
was placed on an aseptic gauze pad sat-
urated with physiological saline over-
lying the wound site, and the return 
electrode (10.0 × 10.0 cm) was attached 
to healthy skin, at least 20 cm from the 
PrU (on a gauze pad saturated with 
physiological saline).
Patients’ PrUs were stimulated with the 
cathode once a day, in keeping with 
clinical studies that found that cathodal 
stimulation accelerated the healing of 
PrUs17,24 and venous leg ulcers.20
The results of in vitro studies show 
that cathodal stimulation induces 
electrotaxis, causing human fibro-
blasts,30,31  keratinocites,36 microvascu-
lar endothelial cells,42 and epithelial 
cells39 to  migrate directorially toward 
the cathode. The results of Bour-
guignon et al’s32,33 in vitro study with 
human fibroblasts show that ca-
thodal stimulation can increase the 
rate of protein and DNA synthesis. 
The in vivo study by Asadi et al40 
has  provided evidence that cathodal 
sensory- level ES increases the release 
of vascular endothelial growth factor 
in skin. In clinical trials performed by 
Franek et  al,18 cathodal ES improved 
granulation tissue growth in VLUs. The 
results of cited studies lead to a con-
clusion that cathodal ES can promote 
granulation tissue formation30–33,40 and 
 epithelialization.36,39
Cathodal plus anodal electrical 
stimulation group (CAG). Patients 
in the CAG received SWC and 
cathodal+anodal HVMPC. The HVMPC 
protocols designed for the CAG and 
CG were only different in that the CAG 
received cathodal stimulation in the 
first week and anodal stimulation for 
the remaining 5 weeks.
The ES protocol for the CAG was pre-
pared, taking into account the results 
of in vivo studies with animals33,34,36,37,40 
and clinical studies18,22,23 showing that 
wounds stimulated first with the cath-
ode and then with the anode heal more 
readily.
In in vivo studies with animals, ex-
perimental wounds were treated by 
 applying HVMPC34,35,41 and microamper-
age direct current (200–300 µA37,38) for 
7–15 days,34,35,37,38,41 with cathodal stim-
ulation being  replaced after the first 
3 days, with anodal stimulation for the 
rest of treatment. A comparison be-
tween the results obtained for the treat-
ed groups and controls (receiving sham 
ES 37,38,41 or no ES et all34,35) showed that 
in the treated groups wounds closed 
significantly faster,34,41 epithelialization 
was more advanced,34,35 and the mean 
number of fibroblasts at day 7 was 
significantly greater as well as mean 
 tissue tensile strength at day 15.38 The 
authors of the studies also noted in-
creased mRNA expression of collagen-I, 
α-smooth muscle actin, and trans-
forming growth factor- β1,41 as well as 
 decreased duration of the inflammato-
ry phase and more advanced wound 
proliferative and maturation phases of 
healing.37
The authors of clinical studies applied 
HVMPC to VLUs18 and PrUs22,23 for a 
period of 622,23 or 718 weeks. After the 
first 1–222 or 1–318 weeks, cathodal 
stimulation was replaced with anodal 
stimulation. The duration of cathod-
al stimulation was adjusted, taking 
into account the amount of pus in the 
wound18 and the rate of granulation 
tissue formation.22 Junger et al,15 who 
used low-voltage monophasic pulsed 
current to treat VLUs, also  adjusted 
the length of cathodal stimulation 
and anodal stimulation following 
changes in wound severity. After the 
first 1–2 weeks, cathode was replaced 
by anode for 3 to 10 days, and then 
the  polarity of the treatment elec-
trode was changed to negative again. 
The overall average wound treatment 
time was 38 days.
In our study, PrUs were of necrotic  tissue 
with approved enzymes in preparation 
for the application of ES. Thus, puru-
lence was not present in the wounds, 
granulation tissue was just beginning to 
form, and all patients  received cathod-
al stimulation in the first week only 
(5 sessions). This approach is relatively 
similar to those used in animal studies, 
in which the authors applied cathod-
al stimulation for the first 3 days. It is 
also consistent with the methodology 
D
ow
nloaded from
 https://academ
ic.oup.com
/ptj/article-abstract/97/8/777/3796345 by m
arquette university R
aynor M
em
orial Libraries user on 17 Septem
ber 2018
Electrical Stimulation With Cathodal Versus Cathodal Plus Anodal Polarities for Pressure Ulcers
August 2017 Volume 97 Number 8 Physical Therapy   781
of clinical trials and ensured that all 
patients in the CAG received uniform 
treatment.
Placebo electrical stimulation group 
(PG). In the PG, SWC and sham ES 
were applied. The positioning of the 
electrodes did not differ from that in the 
ES groups, and the monitor showed all 
parameters, but electrical current was 
not delivered.
All patients were treated using an ES 
device with 2 independent electrical 
circuits, of which only 1 was  active. 
The person connecting the electrodes 
and selecting the polarity of the treat-
ment electrode was the chief  physical 
 therapist. The procedure was  performed 
in an inconspicuous manner so that nei-
ther the patient nor the medical team 
members could see whether real or 
sham ES was applied.
Amperage in the active ES groups was 
set to 0.25 A. The value was also dis-
played for the patients receiving sham 
ES. Active ES did not cause muscle 
contractions in the patients, evoking 
only weak tactile sensations. However 
most patients in all groups had tactile 
sensory problems and were unable to 
feel the current, so patients in the sham 
ES group were not aware of receiving 
sham therapy.
Sham ES in the PG and active ES in 
the ES groups were applied following 
the same protocol (a daily session of 
50 minutes, 5 times a week).
Before and after each ES or placebo 
ES session, electrodes were sterilized 
in approved disinfectant solution In-
cidin Liquid, Ecolab, Germany (Com-
pounds: 2-Propanolum 35%; 1-Pro-
panolum 25%; amphoteric surface 
active bactericidal agents 0.375%), 
and with Sani-Cloth Active, Ecolab, 
Germany (Compounds: didecyldimo-
nium chloride 0.45%). After sessions, 
wounds were thoroughly cleansed 
with a 0.9% sodium chloride solution 
and covered with SWC dressings (see 
above).
In designing the trial, it was assumed 
that wound healing would be moni-
tored in all groups for 6 weeks, ie, an 
average period of a patient staying 
in the facility. Patients hospitalized 
longer than 6  weeks were to receive 
the same treatments, and healing pro-
gress was to be assessed as before. 
Data obtained during the trial and the 
follow-up  periods were subjected to 
the Kaplan-Meier analysis to determine 
the percentages of wounds that did not 
close in particular groups.
In patients with more than 1 PrU, 
all wounds were treated, but only 
the most severe ones were analyzed 
 statistically.
Measures
At least 7 weekly measurements were 
made–before the trial and after each 
week of treatment to evaluate each pa-
tient’s wound surface area (WSA; cm2). 
If a PrU closed before week 6 ended, 
the date of closure was recorded.
To determine the surface area of the 
wounds (WSA), their shapes were first 
traced onto acetate sheets and then 
onto rigid, transparent film to be meas-
ured with a planimeter. The obtained 
data were processed by a digitizer 
 (Mutoh Kurta XGT, ALTEK Information 
Technology Inc, Spokane, Washington) 
connected to a personal computer with 
software C-GEO (version 4.0, Nadowski 
 SoftLine, Poland) that was also used for 
making computations and storing the 
results. A similar method was used by 
the authors of other  clinical  trials.18,22–24
Measurement errors caused by irregular 
wound shapes ranged from 2.7% (PrUs 
70 cm2) to 37.9% (PrUs ulcers <1 cm2). 
The method for calculating measure-
ment errors has been presented in the 
earlier study.22
Outcomes
The primary study outcome was wound 
severity at week 6, as indicated by per-
centage change in WSA (PAR6) from 
baseline.
PAR6 were calculated as:
×PAR6 =
initialWSA cm cm at week 6
InitialWSA cm
( ) – WSA ( )
( )
100%
2 2
2
The secondary outcome was the rate 
at which wound severity changed. To 
estimate it, the approximate amount 
of time that would be needed for PrU 
area to decrease from baseline by 50% 
(T½) was calculated. The amount of 
time  during which WSA was likely to 
decrease from baseline by 50% (T½) 
was estimated by means of nonlinear 
approximation. First, to make sure that 
the WSA change rates were comparable 
regardless of treatment length, the non-
linear approximation of relative wound 
area (WSArel(t)) was calculated:
WSA t WSA t WSA t =( ) = ( ) / ( 0)rel
where WSArel(t) – the relative wound 
area; WSA (t) – the wound area at 
week’s end; WSA (t = 0) – the baseline 
wound area. Accordingly, the relative 
wound area of a wound area of 20 cm2 
at week 0 (baseline) is calculated as 
WSArel(0) = WSA (0) / WSA (t = 0) = 
20 cm2 / 20 cm2 = 1. For a wound area 
of 15 cm2, at week 1, the relative area 
is WSArel(1) = WSA (1) / WSA (t = 0) = 
15 cm2 / 20 cm2 = 0.75 cm2.
The nonlinear approximation was given 
by the following exponential model:
 WSA t( ) =
−
2
t
T
rel
1/2  (1)
where t – week of treatment; T½ - ap-
proximate time over which wound area 
decreases by half.
At week 6, we also calculated as sec-
ondary outcomes the percentages of 
PrUs that closed and the percentages of 
PrUs the WSA of which increased from 
baseline.
In planning the trial, it was assumed that 
changes in wound severity would be 
monitored for a period of 6 weeks, and 
that all members of the study groups re-
maining in the facility beyond this point 
would continue to receive treatment. 
The probabilities of wound non-closure 
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were estimated for all 3 groups using 
the Kaplan-Meier analysis and individ-
ual (real) lengths of treatment, which 
ranged from 3 to 17 weeks.
Statistical Analysis
To determine group sizes for the trial, 
a pilot study was prepared, in which 
3 groups of 8 patients with PrUs were 
treated with cathodal stimulation (CG), 
cathodal stimulation followed by anod-
al stimulation (CAG), and placebo ES 
(PG). At week 6, percentage changes 
in wound surface area from baseline 
(PAR6) were compared between CG 
and PG and CAG and PG. The greatest 
standard deviation of PAR6 calculated 
for the groups (37.88%) and the small-
est between-group difference for PAR6 
(21.52%) indicated that statistically sig-
nificant between-group differences in 
PAR6 could be obtained (at P < .05) 
with study groups of at least 18 partic-
ipants. Because of the likelihood that 
some patients would withdraw from 
the study, we decided to add 2 extra 
persons to each group, which finally 
consisted of 20 persons.
Because wound surface areas measured 
at the end of treatment varied more 
than in the pilot study, statistical analy-
sis focused on the relative wound area 
to minimize the risk of baseline inter-
patient differences biasing the study 
results. The relative wound areas were 
used to determine percentage change in 
WSA at week 6 (PAR6) and to perform 
nonlinear approximation to estimate 
the pace of changes in WSA (WSArel(t)).
To retain data of all randomly allocat-
ed participants, an intention-to-treat 
analysis was conducted. To account 
for the missing data, the exponential 
regression function was used, which is 
useful in describing WSA decreases47 
and can be calculated with data from at 
least 3 weeks. The function is written as 
WSA = b exp(-at), where WSA - wound 
surface area; b (the regression constant) 
and a (the exponential regression coef-
ficient) are calculated for each patient 
using WSA values (cm2) obtained over 
the period of treatment; exp – the expo-
nential regression function with a base 
of e ≈  2.718282 (the Euler’s number); 
t  –  time (week of treatment). In this 
trial, the exponential correlation coeffi-
cient was negative for each patient and 
higher than 0.9 for the absolute wound 
surface area.
Patients’ characteristics were tested for 
normal distribution using the Shap-
iro-Wilk W-test. When distributions 
were not normal, the non-parametric 
tests were performed. The distributions 
were tested for skewness, kurtosis, 
and modality. Because skewness and 
kurtosis were always smaller than 4 
and the distributions were unimodal, 
the central value and dispersion were 
measured with a mean and a standard 
deviation.
The within-group homogeneity of pa-
tients’ characteristics before treatment 
was tested using the 2-sided Fisher  exact 
test, the ANOVA Kruskal-Wallis test, and 
the Kruskal-Wallis post-hoc test.
The between-group comparisons of 
mean PAR6 were made using the ANO-
VA Kruskal-Wallis test and Kruskal-Wal-
lis post-hoc test.
The amount of time necessary for 
wound area to decrease from baseline 
by at least 50% was estimated using 
nonlinear approximation and an expo-
nential model (1).
The percentages of PrUs that closed 
and the percentages of PrUs the surface 
area of which increased were compared 
between the groups at week 6 using the 
2-sided Fisher exact test.
The Kaplan-Meier percentages of PrUs 
that did not close during treatment 
were compared between the 3 trial 
groups using the chi-square test. The 
within-group differences were tested 
for statistical significance by means of 
the Gehan-Wilcoxon test.
In all cases the level of significance was 
P < .05. All statistical analyses were per-
formed by a blinded person using the 
Statistica software (version 10.0, Stat-
Soft Polska Sp. z o.o.).
Research Funding Source
The study was funded by the Academy 
of Physical Education.
Results
Between September 21, 2014, and 
June  1, 2015, a group of 71 persons 
was screened for the trial. Eight indi-
viduals were excluded for meeting the 
inclusion criteria, and the remaining 
63 persons were randomly allocated 
to the following groups: CG (23), CAG 
(20), and PG (20). Six patients (9.52%) 
dropped out before the end of treat-
ment, but all patients were treated for 
3 weeks minimum.
The flow of participants through the 
 trial is illustrated in Figure 1.
The between-group comparisons of 
PAR6 and the estimations of the amount 
of time during which PrUs might de-
crease by half (non-linear approxi-
mations) were made using data on all 
patients, including those who dropped 
out from the study (63 patients). In the 
Kaplan-Meier analysis the actual data 
were used because this analysis can be 
performed on the base of complete ob-
servations (closed wounds) and cut-off 
observations (patients who drop out of 
the study).
Baseline Characteristics
The demographic and wound charac-
teristics of patients in the 3 comparative 
groups show (Tables 1 and 2) that at 
baseline the groups were not statistical-
ly significantly different for any of the 
considered variables.
The sample consisted of 52 female pa-
tients (82.53%) and 11 male patients 
(17.46%) aged 60 to 95 years, most-
ly older than 80 years (35; 55.51%). 
 Forty-nine patients (77.78%) were 
 immobile. Forty-one patients (65.08%) 
were diagnosed with generalized ath-
erosclerosis, 27 (42.86%) had type 
2 diabetes (HbA1C < 7%), and 24 
(38.09%) were cerebral stroke patients. 
In 19   malnourished patients (30.16%), 
 nutrition  therapy was applied.
The patients had a total of 63 PrUs rang-
ing in size from 0.5 to 39.10 cm2; 36 PrUs 
were Category II (57.14%), 25 Category 
III (39.68%), and 6 Category IV (9.52%). 
Thirty-seven (58.73%) developed in 
the sacral region, 10  (15.87%) on the 
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ischial tuberosity, and 16 (25.4%) on 
the trochanter. Sixteen patients (25.4%) 
had multiple PrUs, and in 37 (58.73%) 
recurrent PrUs were diagnosed. The 
pre-trial duration of patients’ PrUs was 
1–8 months, mostly 1–3 months (36; 
57.14%).
The groups did not differ at baseline 
for any patients’ characteristics (P > .05; 
 Tables 1 and 2).
Primary outcome. The cumulative 
change indicated by PAR6 was 82.34% 
(95% CI 70.06-94.63) in the CG, 70.77% 
(95% CI 53.51–88.04) in the CAG, 
and 40.53% (95% CI 23.60-57.46) in 
the PG. Results obtained for CG were 
statistically more significant than those 
obtained for PG. Confidence intervals 
for mean PAR6 values overlapped 
between CG:CAG and CAG:PG, but the 
PG’s mean PAR6 was smaller than the 
smallest confidence intervals for CAG, 
meaning that results obtained for CAG 
were statistically more significant than 
those obtained for PG. The CG and 
CAG were not statistically significantly 
different from each other (Table 3).
Secondary outcomes. According to 
nonlinear approximation results, in the 
CG WSA would decrease from baseline 
by half (T1/2) over 1.92 (95% CI 1.62-2.23) 
week of treatment, 2.60 (95% CI 2.08-
3.13) weeks in the CAG, and 10.60 (95% 
CI 7.25-13.95) in the PG. The analysis of 
confidence intervals for T1/2 showed that 
the periods were statistically significant 
different between CG and PG and 
between CAG and PG, but not between 
CG and CAG (Figure 2; eTable, available 
at academic.oup.com/ptj).
More PrUs closed during the 6 weeks of 
treatment in the CG (11 of 23 = 47.83%) 
and the CAG (9 of 20 = 45%) than in 
the PG (0 of 20 = 0%); P = .013 and 
P = .045, respectively. The percentages 
of PrUs that closed in the CG and CAG 
were not statistically significantly dif-
ferent (P = .48). Measurements at week 
6 showed that unlike the CG, where no 
PrUs had increased in size from base-
line, in the CAG and PG 1 and 2 PrUs, 
respectively, were larger. The differenc-
es between groups were not statistically 
significant (P > .05).
CG accounted for the smallest ratio of 
PrUs that did not close (Figure 3) and PG 
for the highest. CG and CAG were not 
statistically significantly different in that 
respect. Statistically significant differenc-
es were found between CG and PG and 
between CAG and PG in favor of CG and 
CAG. The result of the chi-square test for 
all 3 groups was P < .01. The results of 
between-group  comparisons made with 
Figure 1. 
Flow diagram of the study. ES = electrical stimulation.
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Table 1. 
Baseline Patient Characteristics (No. of patients = 63)a
Variable Cathode ES group (n = 23) Cathode + anode ES group (n = 20) Placebo ES group (n = 20)
Gender [n (%)]:
 Female
 Male
17 (73.91%)
6 (26.09%)
18 (80%)
2 (10%)
17 (85%)
3 (15%)
Age [years]: Average (SD) 79.35 (8.48) 79.65 (11.44) 77.55 (12.24) 
No. of people in age [years (%)]:
 60–69 years
 70–79 years
  ≥80 years
2 (8.7%)
9 (39.13%)
12 (52.17%)
4 (20%)
4 (20%)
12 (60%)
4 (20%)
5 (25%)
11 (55%)
BMI [no. of patients (%)]:
 BMI > 30
 BMI < 19
2 (8.7%)
2 (8.7%)
3 (15%)
2 (10%)
3 (15%)
1 (5%)
Unable to change position unaided
 [no. of patients (%)] 18 (78.26%) 16 (80%) 15 (75%)
Concomitant diseases
 [no. of patients (%)]:
 General atherosclerosis
 Diabetes (HbA1C < 7%)
 Cerebral strokes
15 (65.22%)
10 (43.48%)
7 (30.43%)
11 (55%)
10 (50%)
11 (55%)
15 (75%)
7 (35%)
6 (30%)
No. of patients with malnutrition
(%) 7 (30.43%)
5 (25%)
7 (35%)
No. of patients with multiple PrUs (%) 7 (30.43%) 6 (30%) 3 (15%)
aBMI = body mass index, PrUs = pressure ulcers.
Table 2. 
Baseline PrU Characteristics (No. of patients = 63)
Variable Cathode ES group (n = 23) Cathode + anode ES group (n = 20) Placebo ES group (n = 20)
WSA of PrUs [cm2]:
mean (SD) 9.59 (10.48) 7.37 (5.95) 8.90 (7.21)
Duration of PrUs [months]:
mean (SD) 2.41 (1.68) 2.65 (2.20) 3.03 (2.22)
No. of PrUs of duration (%): 
 1–3 months
 3.1–6 months
 6.1–12 months
14 (60.87%)
7 (30.43%)
2 (8.7%)
12 (60%)
6 (30%)
2 (10%)
10 (50%)
7 (35%)
3 (15%)
PrU severity according to NPUAP scale 
[no. of patients (%)]:
 Category II°
 Category III°
 Category IV°
12 (52.17%)
9 (39.13%)
2 (8.7%)
11 (55%)
6 (30%)
3 (15%)
13 (65%)
6 (30%)
1 (5%)
Location [no. of PrUs (%)]:
 Sacrum
 Ischial tuberosity
 Trochanter major
11 (47.83%)
4 (17.39%)
8 (34.78%)
13 (65%)
3 (15%)
4 (20%)
13 (65%)
3 (15%)
4 (20%)
aPrU(s) = pressure ulcer(s), WSA = wound surface area, NPUAP = National Pressure Ulcer Advisory Panel.
the Gehan-Wilcoxon test were P = .64 
(CG vs. CAG); P < .01 (CG vs. PG); and 
P < .01 (CAG vs. PG).
Discussion
Statement and Principal Findings
The trial has showed that in elderly 
persons an SWC program enhanced by 
HVMPC can reduce PrU surface area 
statistically significantly more than SWC 
alone. In both groups receiving electri-
cal stimulation PrUs decreased by half 
statistically significantly faster, more 
PrUs closed by the end of treatment 
(week 6), and the probability of PrUs not 
closing within a period of 3 to 17 weeks 
was lower (Kaplan- Meier Analysis) than 
in the placebo group. This supports our 
hypothesis that SWC combined with 
HVMPC programs is more effective in 
treating PrUs than SWC alone.
The results of in vitro and in vivo 
studies show that the polarity of the 
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treatment electrode is important to 
wound healing,30–42 but protocols spec-
ifying how the cathode and the anode 
should be applied to chronic wounds 
in  humans are yet to be developed. In 
this trial, 1 group received cathodal 
stimulation for 6 weeks, and in the sec-
ond group cathodal stimulation was re-
placed after the first week with anodal 
stimulation, which was applied for the 
remaining 5 weeks. Treatment results 
between groups treated with HVMPC 
were not statistically significantly dif-
ferent, which supports the second 
 hypothesis stating that cathodal stimu-
lation applied to PrUs for a period of 
6 weeks and cathodal stimulation used 
in the first week and anodal stimulation 
during the next 5 weeks offer similar 
therapeutic effects.
Clinical studies comparing the influ-
ence of cathodal and cathodal plus an-
odal HVMPC on the healing of PrUs are 
not available, but according to some re-
ports both types of ES can be effective. 
For instance, Griffin et al,17 Houghton 
et al,20 and Polak et al24 chose cathod-
al stimulation to treat PrUs17,24 and 
VLUs.20 Franek et al18,22 treated wounds 
using cathodal stimulation during the 
first 1–3 weeks (VLUs18) and 1–2 weeks 
(PrUs22). In both studies,18,22 it was 
replaced by anodal stimulation until 
treatment end. Houghton et al21 treated 
PrUs with cathodal simulation in the 
first week and then changed polarity 
every week.
The authors of many studies who 
treated PrUs12–14 and VLUs15 with 
low- voltage rectangular monophasic 
pulsed current also used the cathode 
and  anode as the treatment electrode, 
always starting therapy with cathodal 
stimulation. They changed the polar-
ity of the treatment electrode every 
3  days12–14 or,  depending on healing 
progress, used cathodal stimulation 
during the first 1–2  weeks, anod-
al stimulation for the next 3-10 days, 
and then changed  polarity to negative 
again.15
Table 3. 
Cumulative Change in Wound Size (n = 63)
Mean (SD) / 95% CI
Group Wound surface area [cm2]
Percentage area reduction at week 6 [%]Before treatment After treatment
CG (A) n = 23 9.59 (10.48) / 5.05 – 14.12 2.46 (6.21) / –0.32 – 5.05 82.34 (28.41) / 70.06 – 94.63
CAG (B) n = 20 7.37 (5.95) / 4.59 – 10.15 1.32 (5.05) / 1.32 – 6.05 70.77 (36.89) / 53.51 – 88.04
PG (C) n = 20 8.90 (7.21) / 5.52 – 12.27 6.42 (6.88) / 3.20 – 9.64 40.53 (36.1) / 23.60 – 57.46
Level of significance P(ABC) = .0004a
P(AB) = .9932b
P(AC) = .0006b
P(BC) = .0124b
aANOVA Kruskal-Wallis test.
bpost-hoc Kruskal-Wallis test.
Figure 2. 
Results of nonlinear exponential approximation showing the amount of time necessary for 
wound area to decrease by half from baseline (dots are observed mean values of relative 
wound surface area; whiskers represent 95% confidence interval). The treatment duration 
necessary for wound surface area to decrease from baseline by half (T1/2) is 1.92 weeks 
(95% CI 1.62-2.23) in the CG, 2.60 weeks (95% CI 2.08-3.13) in the CAG, and 10.60 weeks 
(95% CI 7.25-13.95) in the PG. The analysis of confidence intervals for T1/2 has shown that 
the values are statistically significantly different between CG and PG and between CAG and 
PG. CG = cathodal group, CAG = cathodal+anodal group, PG = placebo group.
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Notwithstanding this variety of proto-
cols, positive effects of ES are consist-
ently reported. This seems to imply that 
the polarity of the treatment electrode 
can be selected for the stage of wound 
healing rather than following a standard 
protocol.
Both in vitro30,31,36,39,48,49 and in 
vivo50 studies have demonstrated that 
both the cathode and anode can induce 
electrotaxis, causing cells important 
for wound healing to travel toward the 
wound.
Anodal stimulation facilitates the 
electrotaxis of macrophages48 and 
neutrophiles49,50 for autolysis and re-
activation of the inflammatory phase 
of healing, as well as promoting the 
electrotaxis of vascular fibroblasts, 
vascular smooth muscle cells, and 
umbilical vein  endothelial cells for 
 angiogenesis.42
Fibroblasts,30,31 keratinocytes,36 micro-
vascular endothelial cells,42 and epithe-
lial cells38 migrate toward the cathode, 
which enhances the proliferative phase 
of wound healing.
Becker51 has found anodal stimulation 
to be able to amplify the local positive 
injury content.16 In the in vivo study 
by Talebi et al,52 the anode restored 
wound potential in acute skin wounds 
to the preinjury level and acute skin 
wounds closed faster. Borba et al53 
have observed in rats improved ne-
oangiogenesis in the early stage of 
acute wound healing under the influ-
ence of anodal stimulation.
The authors of in vitro studies have 
shown that cathodal stimulation im-
proves collagen synthesis in fibro-
blasts,32,33 and in in vivo studies its 
 ability to increase the release of vascu-
lar endothelial growth factor in skin has 
been demonstrated.40
Reports from in vivo studies where a 
combination of cathodal and anodal 
stimulation was used point to faster 
wound epithelialization34,35,38 and great-
er wound tensile strength,38 as well 
as to increased mRNAs expression of 
collagen-1, α-smooth muscle action, 
and transforming growth factor-β1.41 
In the study by Demir et al,37 cathodal 
stimulation followed by anodal stimu-
lation reduced the number of polymor-
phonuclear leucocytes, macrophages, 
and mast cells in the wounds, thus 
Figure 3. 
Kaplan-Meier probability for all 63 patients of wound non-closure after a real time of treatment. Statistically significant differences were found 
between CG and PG and between CAG and PG in favor of CG and CAG. The result of the chi-square test for all 3 groups was P < .01. The 
results of between-group comparisons made with the Gehan-Wilcoxon test were P = .64 (CG vs. CAG); P < .01 (CG vs. PG); and P < .01 (CAG 
vs. PG). CG = cathodal group, CAG = cathodal+anodal group, PG = placebo group.
D
ow
nloaded from
 https://academ
ic.oup.com
/ptj/article-abstract/97/8/777/3796345 by m
arquette university R
aynor M
em
orial Libraries user on 17 Septem
ber 2018
Electrical Stimulation With Cathodal Versus Cathodal Plus Anodal Polarities for Pressure Ulcers
August 2017 Volume 97 Number 8 Physical Therapy   787
shortening the inflammatory stage. By 
increasing the number of fibroblasts 
and stimulating collagen synthesis and 
maturation, they also supported wound 
proliferation and remodeling.
Strengths and weaknesses of the 
study. The main strengths of the trial 
include the blinding of the research 
team (physicians, nurses, physical 
therapists), the person measuring WSA, 
and the statistician; the trial participants 
were hospitalized, so PrU prevention 
measures and treatment could be 
uniformly applied under the supervision 
of the medical staff and the ES protocol 
was consistently observed; valid and 
reliable acetate tracings were used to 
measure wound sizes; the drop-out rate 
was relatively low; and in the intention-
to-treat analysis the exponential 
regression function was used, with 
which WSA decreases can be precisely 
represented.
Limitations
The major limitation of the trial is that 
most PrUs were treated not longer than 
6 weeks. The period was too short for 
all PrUs to close. Consequently, we 
could not determine how long cathodal 
or cathodal+anodal HVMPC should be 
applied to cause the closure of Catego-
ry II-IV PrUs. Monitoring the healing 
of patients’ PrUs after the trial was not 
possible either, because some were dis-
charged from the hospital to be treated 
at homes, and a number of others were 
moved to other wards for treatment for 
concomitant diseases.
The PrU prevention and treatment 
program for all 3 groups generally fol-
lowed the same best practice recom-
mendations,1,2,44 but its specific solu-
tions addressed the needs of individual 
patients. The blinding rate of patients 
and assessors was not assessed.
Strengths and weaknesses in 
relation to other studies; important 
differences in results. Our results are 
consistent with the results obtained by 
other researchers treating PrUs with 
HVMPC.16,17,21–24
The primary research outcome in our 
trial was percentage decrease in wound 
surface area, which was also used in 
other clinical studies to evaluate the 
efficacy of wound treatment.16–24 We 
found the WSA of Category II-IV PrUs 
to be smaller at week 6 by 82.34% and 
70.77% in the cathodal ES group and 
the cathodal+anodal ES group, respec-
tively. These results are comparable 
with the results obtained by other au-
thors who also used HVMPC. Griffin 
et al17 reported an 80% decrease in 
the area of Category II-IV PrUs after 3 
weeks of cathodal ES. Polak et al24 re-
ported an 80.31% decrease in the area 
of Category II-III PrUs after 6 weeks of 
cathodal ES. In Franek et al22 and Polak 
et al,23 studies on Category II-IV PrUs, 
6 weeks of intervention with cathod-
al+anodal ES, yielded PAR of 88.9% and 
76.19%, respectively. Sixteen Category 
II-IV PrUs (mostly Category III-IV PrUs 
(93.73%)) in Houghton et al21 decreased 
after 12 weeks of treatment with cath-
ode plus anode by an average of 70.0%.
The reviews of clinical studies point also 
to wound closure as another important 
surrogate endpoint.27 In our trial, 47.83% 
(CG) and 45% (CAG) of PrUs treated 
with HVMPC closed  after 6 weeks (most-
ly Category II PrUs and only 1  Category 
III-IV PrU in each ES groups). In the 
study by Houghton et  al,21 37.5% of 
PrUs closed after 12 weeks of treatment, 
but it needs to be noticed that in the ES 
group as much as 81.25% of them were 
Category III-IV. In this study,  Category 
III-IV PrUs  accounted for 47.83% and 
40% in the CG and CAG, respectively.
Significance of the Study: 
Possible Explanations and 
Implications for Clinicians and 
Policymakers
Our HVMPC protocol was designed fol-
lowing those used by other authors.16–23 
The sterilized treatment electrode was 
placed on the wound and the return 
electrode on intact periwound skin 
about 20 cm from the wound edge. 
The electrodes were separated from the 
tissue by sterile gauze pads moistened 
with physiological saline to improve 
electrical conductivity and maintain 
moist wound environment.
HVMPC with twin-peaked pulses of 
154 µs, frequency of 100 pps, 0.25 A, 
and electric charge of 250 µC/sec in the 
voltage range from 100 to 150 V that 
we and  other authors selected to treat 
PrUs,16,17,21–24 venous leg ulcers,18,20 and 
diabetic foot ulcers19 is reported to be ef-
fective. Following the protocols used by 
other researchers,16–24 we applied amper-
age that only caused sub-motor reactions.
Most authors16–18,20,22–24 treated PrUs 
with HVMPC for 45–60 minutes, once a 
day, 5–7 days a week, so the total dura-
tion of ES in their studies ranged from 
3.75 to 7 hours per week. Our sessions 
were similar in duration (50-minutes 
5  days/week; total treatment time of 
4.16 hours of a week).
Side effects. Neither we nor other 
researchers found HVMPC to have 
adverse effects.
Our patients, elderly individuals at high 
risk of PrU development, were relative-
ly similar at baseline regarding wound 
healing determinants such as age, 
wound duration, severity, and size. The 
treatment we applied proved effective 
despite these unfavorable circumstances. 
Patients in the ES groups received also 
an interdisciplinary wound management 
program consistent with the best prac-
tice guidelines on PrU treatment.1,2
Unanswered questions and future 
research. There are many preclinical 
studies, the results of which show that 
the polarity of the treatment electrode 
is important in treating chronic wounds. 
Our clinical trial appears, however, to be 
the first one that compares the healing 
of PrUs treated with HVMPC delivered 
according to 2 different polarity 
protocols. Further clinical studies are 
necessary to determine how the specific 
polarity of the treatment electrode 
influences wound healing processes.
Conclusions
Our trial has shown that HVMPC 
(154 µs; 100 pps; 100 V; 250µC/sec) ap-
plied 50 minutes a day, 5 times a week, 
with the cathode as the only treatment 
electrode or the cathode in the first 
week and then the anode, is effective in 
treating Category II-IV PrUs. Both types 
of ES reduced the surface area of PrUs 
and accelerated their healing.
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Our results are consistent with the 
 results of other researchers who found 
HVMPC to improve the healing of 
chronic wounds, including PrUs.
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